Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer ; day:27 ; month:4 ; year:2016 ; pages:1-14
Breast cancer research and treatment ; (27.4.2016), 1-14
- Creator
-
Thakkar, A.
- Contributor
-
Wang, B.
Picon-Ruiz, M.
Buchwald, P.
Ince, Tan A.
SpringerLink (Online service)
- DOI
-
10.1007/s10549-016-3807-y
- URN
-
urn:nbn:de:1111-201604297591
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Thakkar, A.
- Wang, B.
- Picon-Ruiz, M.
- Buchwald, P.
- Ince, Tan A.
- SpringerLink (Online service)
Other Objects (12)
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer